Sheila Gujrathi Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sheila Gujrathi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sheila Gujrathi. Sheila Gujrathi is Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Chief Medical Officer in Receptos, Inc. ($RCPT) and Director in Turning Point Therapeutics, Inc. ($TPTX) and President & CEO in Gossamer Bio, Inc. ($GOSS).
Latest Insider Trading Transactions of Sheila Gujrathi
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FPRX, GOSS, RCPT, TPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2020 | TPTX | Turning Point Ther ... | Gujrathi Sheila | Director | Option Exercise | A | 65.39 | 8,500 | 555,815 | 8,500 | |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | A | 14.55 | 292,000 | 4,248,600 | 292,000 | |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Grant | A | 0.00 | 189,500 | 0 | 189,500 | 0 to 189.5 K |
| Sep 27 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Buy | P | 16.80 | 10,000 | 167,980 | 4,048,242 | 4 M to 4 M (+0.25 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Gujrathi Sheila | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | A | 22.10 | 380,000 | 8,398,000 | 380,000 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | C | 0.00 | 55,957 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | C | 0.00 | 223,182 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Buy | C | 0.00 | 62,030 | 0 | 4,038,242 | 4 M to 4 M (+1.56 %) |
| May 14 2018 | FPRX | FIVE PRIME THERAPE ... | Gujrathi Sheila | Director | Option Exercise | A | 17.27 | 10,000 | 172,700 | 10,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | Gujrathi Sheila | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Gujrathi Sheila | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| Dec 03 2015 | FPRX | FIVE PRIME THERAPE ... | Gujrathi Sheila | Director | Option Exercise | A | 37.99 | 25,000 | 949,750 | 25,000 | |
| Aug 27 2015 | RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Offic ... | Option Exercise | D | 41.51 | 55,418 | 2,300,401 | 0 | |
| Aug 27 2015 | RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Offic ... | Option Exercise | D | 18.77 | 129,400 | 2,428,838 | 0 | |
| Aug 27 2015 | RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Offic ... | Option Exercise | D | 8.10 | 26,666 | 215,995 | 0 | |
| Aug 27 2015 | RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Offic ... | Sell | D | 0.00 | 12,500 | 0 | 0 | 12.5 K to 0 (-100.00 %) |
| Aug 27 2015 | RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Offic ... | Sell | U | 0.00 | 120,661 | 0 | 12,500 | 133.2 K to 12.5 K (-90.61 %) |
| Apr 03 2015 | RCPT | Receptos, Inc. | Gujrathi Sheila | Chief Medical Offic ... | Grant | A | 0.00 | 12,500 | 0 | 133,161 | 120.7 K to 133.2 K (+10.36 %) |
Page: 1